12th Nov 2021 5:51 pm |
RNS |
Issue of Equity |
12th Nov 2021 7:00 am |
RNS |
Participation at Jefferies healthcare conference |
11th Nov 2021 7:00 am |
RNS |
Parsortix system showcased at NCRI Festival |
10th Nov 2021 5:40 pm |
RNS |
Issue of Equity |
2nd Nov 2021 7:00 am |
RNS |
Change of Adviser |
21st Oct 2021 5:25 pm |
RNS |
Issue of Equity |
15th Oct 2021 5:45 pm |
RNS |
Issue of Equity |
30th Sep 2021 4:02 pm |
RNS |
Issue of Equity |
30th Sep 2021 7:00 am |
RNS |
Interim Results |
27th Sep 2021 7:00 am |
RNS |
Parsortix demonstrates ability to isolate CTCs |
22nd Sep 2021 7:00 am |
RNS |
Study shows use of Parsortix to assess PD-L1 |
20th Sep 2021 7:00 am |
RNS |
Parsortix enables gene expression analysis in mPCa |
7th Sep 2021 7:00 am |
RNS |
Notice of Interim Results and Webcast |
24th Aug 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
9th Aug 2021 7:00 am |
RNS |
Study highlights superior performance of Parsortix |
6th Aug 2021 1:17 pm |
RNS |
Issue of Equity |
3rd Aug 2021 3:13 pm |
RNS |
Issue of Equity |
28th Jul 2021 7:00 am |
RNS |
Contract secured for bespoke assay development |
9th Jul 2021 7:00 am |
RNS |
Harvesting CTCs from brain metastasis patients |
7th Jul 2021 6:34 pm |
RNS |
Director/PDMR Shareholding |
2nd Jul 2021 10:45 am |
RNS |
Issue of Equity |
30th Jun 2021 3:44 pm |
RNS |
Result of AGM |
25th Jun 2021 7:00 am |
RNS |
Result of Accelerated Bookbuild |
24th Jun 2021 6:28 pm |
RNS |
Accelerated bookbuild to raise up to £20m |
18th Jun 2021 11:42 am |
RNS |
Annual General Meeting update |
18th Jun 2021 7:00 am |
RNS |
ctDNA and CTCs have differences in EGFR mutations |
4th Jun 2021 7:00 am |
RNS |
Update on submission for FDA clearance |
1st Jun 2021 7:00 am |
RNS |
Potential to prevent breast cancer relapse |
20th May 2021 7:00 am |
RNS |
Parsortix demonstrates oesophageal cancer utility |
19th May 2021 4:37 pm |
RNS |
Exercise of options and total voting rights |
11th May 2021 7:00 am |
RNS |
Parsortix study uncovers targets in TNBC patients |
30th Apr 2021 11:22 am |
RNS |
Exercise of options and total voting rights |
29th Apr 2021 7:00 am |
RNS |
Preliminary Results |
26th Apr 2021 7:00 am |
RNS |
Ovarian cancer study patient enrolment completed |
19th Apr 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
19th Apr 2021 2:00 pm |
RNS |
Price Monitoring Extension |
19th Apr 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
19th Apr 2021 11:00 am |
RNS |
Price Monitoring Extension |
16th Apr 2021 7:00 am |
RNS |
First large-scale pharma services contract secured |
15th Apr 2021 4:10 pm |
RNS |
Notice of Preliminary Results and Webcast |